Abstract

As most PVs are innately and inherently stenotic, the effective orifice area (EOA) of a PV is frequently small in relation to the patient’s body size, an important phenomenon known as prosthesis/patient mismatch (PPM). In aortic valves, PPM is defined1 as moderate when the indexed EOA is ≤ 0.85 cm/m and is defined as severe when the indexed EOA is ≤ 0.65 cm/ m. In the mitral valve, the cutoff points are 1.2 and 0.9 cm/m, correspondingly. Importantly, PPM has been linked to suboptimal symptomatic improvement, weakened exercise capacity, pulmonary artery hypertension, incomplete regression of left ventricular hypertrophy, increased heart events, and even mortality rates after valve replacement (2-4) According to the literature, PPM is the most common cause of an increased transprosthetic gradient; however, it is essential to distinguish this state from other acquired PV stenoses, which may result from significant leaflet calcification on bioprosthetic valves and pannus overgrowth or thrombus creation on mechanical PVs.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.